The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Walder Wyss Ltd

SEEFELDSTRASSE 123, PO BOX 1236, 8034 ZURICH, SWITZERLAND
Tel:
Work +41 58 658 58 58
Fax:
Fax +41 58 658 59 59
Email:
Web:
www.walderwyss.com

lic iur Luc Defferrard

Tel:
Work +41 58 658 55 47
Email:
Walder Wyss

Work Department

Banking & Finance / M&A / Corporate

Position

Partner

Career

Qualified in 1989. From 1990 to 1997, project manager at UBS (financing department). From 1998 to 1999, associate at another Swiss law firm. Joined Walder Wyss in 1999. Partner at Walder Wyss since 2001.

Languages

French, English and German.

Member

Zurich and Swiss Bar Association.

Education

University of Geneva (lic. iur., 1987).


Switzerland

Banking and finance: Zurich

Within: Leading individuals

Luc Defferrard - Walder Wyss Ltd

Within: Banking and finance: Zurich

Walder Wyss Ltd hosts 'a large team of excellent professionals in banking and finance', who stand out for their 'client-focused and forward-thinking' attitude. Focus areas include lending and structured finance transactions at a domestic or international level, regulatory advice, fund management, banking M&A and representation in investigations. 'Debt finance transaction expert' Lukas Wyss assisted Deutsche Private Equity with the leveraged acquisition financing concerning the purchase of AWK Group, while 'analytical and business-oriented' Theodor Härtsch acts as a core adviser to Perusa, Helvetica Property Investors and Equatex on regulatory issues. Luc Defferrard is another name to note.

[back to top]

Leading firms: German-speaking Switzerland

Within: Leading firms: German-speaking Switzerland

With offices in Zurich, Bern and Basel, Walder Wyss Ltd provides superior advice on capital markets, employment, competition, litigation, real estate, tax, intellectual property and TMT matters. Luc Defferrard, Ueli Sommer, Philippe Nordmann, Markus Frick, Magda Streuli-Youssef, Hans Rudolf Trüeb, Mark Reutter and Thomas Meister are the core partners.

[back to top]


Back to index

Legal Developments by:
Walder Wyss

  • 17 February 2017: Auris Medical's Public Equity Offering

    Auris Medical Holding AG (NASDAQ: EARS) issued and priced its public offering of 10,000,000 common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.70 of a common share.  The common shares and warrants are being sold in units comprised of one common share and one warrant at the public offering price of USD 1.00 per unit. The warrants will be immediately exercisable at a price of USD 1.20 per common share and are exercisable for five years. In connection with the offering, the Company has granted the underwriter a 30-day option to purchase up to 1,500,000 additional common shares and/or 1,500,000 additional warrants at the public offering price less underwriting discounts. The offering is expected to close on or about February 21, 2017, subject to customary closing conditions. Roth Capital Partners is acting as sole book-running manager in the offering. Maxim Group LLC is acting as a financial advisor in the offering.
    - Walder Wyss Ltd

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to